Table 2.
Histological results | Total | |||||
---|---|---|---|---|---|---|
Normal | CIN 1 | CIN 2 | CIN 3/CI | SCC/AC | ||
Number of subjects | ||||||
N | 109 | 23 | 36 | 45 | 29 | 242 |
(%) | (45.04%) | (9.50%) | (14.88%) | (18.60%) | (11.98%) | (100%) |
Age | 43.1 ± 10.1 (21.8 to 75.0) | |||||
Mean age | 42.39 | 48.54 | 39.07 | 41.77 | 48.8 | 43.13 |
(Min to max) | (22.18 to 74.97) | (28.98 to 66.17) | (21.76 to 64.57) | (27.84 to 57.00) | (33.98 to 65.14) | (21.76 to 74.97) |
Cytology results | ||||||
ASC-US | 103 | 20 | 32 | 29 | 15 | 199 |
(%) | (51.75%) | (10.05%) | (16.08%) | (14.57%) | (7.53%) | (100%) |
ASC-H | 6 | 3 | 4 | 16 | 14 | 43 |
(%) | (13.95%) | (6.97%) | (9.30%) | (37.20%) | (32.55%) | (100%) |
ZNF582 m | ||||||
Number | 18 | 8 | 13 | 36 | 25 | 100 |
(%) | (16.51%) | (34.78%) | (36.11%) | (80.00%) | (86.20%) | (41.32%) |
HPV-HR | ||||||
Number | 57 | 13 | 33 | 45 | 29 | 177 |
(%) | (52.29%) | (56.52%) | (91.67%) | (100%) | (100%) | (73.14%) |
AC, adenocarcinoma of the uterine cervix; ASC-H, atypical squamous cells, high-grade squamous intraepithelial lesions could not be excluded; ASC-US, atypical squamous cells of undetermined significance; CIN, cervical intraepithelial neoplasia; CIS, carcinoma in situ; HPV-HR, high risk human papillomavirus; SCC, squamous cell carcinoma.